Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Holding TWST?
Track your performance easily
TWST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.42 - $60.90
Previous Close$46.44
Volume1.41M
Average Volume (3M)948.99K
Market Cap
$2.72B
Enterprise Value$2.52B
Total Cash (Recent Filing)$289.42M
Total Debt (Recent Filing)$87.18M
Price to Earnings (P/E)―
Beta3.28
Next Earnings
Nov 15, 2024EPS Estimate
-$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.81
Shares Outstanding58,585,960
10 Day Avg. Volume895,331
30 Day Avg. Volume948,994
Standard Deviation0.21
R-Squared0.19
Alpha0.00574
Financial Highlights & Ratios
Price to Book (P/B)5.54
Price to Sales (P/S)9.22
Price to Cash Flow (P/CF)-106.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.88
Enterprise Value/Gross Profit28.07
Enterprise Value/Ebitda-12.35
Forecast
1Y Price Target
$50.14Price Target Upside7.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Twist Bioscience News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTWST delivered a healthy revenue beat at $81.5M and management raised 2024 guidance to $310-311M, expecting gross margin to be 42% for the year.
Market DemandElevated pricing premiums could be seen as thematically positive for TWST demand.
Product LaunchTWST began an expanded commercial launch of its Express Genes offering after an initial access launch to existing customers.
Bears Say
Financial PerformanceNet loss was $85.6M, or $1.47/share, which includes ~$44.9M of asset impairment related to biopharma.
Market CompetitionCompetition for Express Gene could intensify and challenge premium pricing.
Operational ChallengesTWST has to have two different computer systems set up in China because the government has complete oversight of its passwords and everything else.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $14.42 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Currently, no data Available
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Nov 15, 2024 which is 5 days ago.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Aug 02, 2024. The company reported -$1.47 earnings per share for the quarter, missing the consensus estimate of -$0.764 by -$0.706.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -$0.7.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 58,585,960 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$1.47 in its last earnings report, missing expectations of -$0.764. Following the earnings report the stock price went down -19.001%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Among the largest hedge funds holding Twist Bioscience Corp’s share is ARK Investment Management LLC. It holds Twist Bioscience Corp’s shares valued at 302M.
---
Twist Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.14 (7.97% Upside)
$50.14 (7.97% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 87%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 95.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
129.90%
12-Months-Change
Fundamentals
Return on Equity
-38.36%
Trailing 12-Months
Asset Growth
-21.25%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q3 2024
0:00 / 0:00
---
TWST Stock 12 Month Forecast
Average Price Target
$50.14
▲(7.97% Upside)
Technical Analysis
Crispr Therapeutics AG
―
Intellia Therapeutics
―
Beam Therapeutics
―
Editas Medicine
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
-0.15%
reiterated a buy rating 4 months ago
Copying Steven Mah's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -0.15% per trade.
---